Capadenoson
Alternative Names: BAY 68-4986Latest Information Update: 07 May 2013
At a glance
- Originator Bayer HealthCare
- Class Ischaemic heart disorder therapies; Nitriles; Pyridines; Thiazoles
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Angina pectoris; Atrial fibrillation